[Clinical experiences with thymopentin administered by intra- and periarticular routes in degenerative pathology of the shoulder, knee and hip].
The aim of this study was to assess the efficacy and tolerability of thymopentin, a synthetic pentapeptide with an immunomodulating action, in treating patients suffering from gonarthrosis, coxarthrosis and scapolo-omeral periarthritis by evaluating pain when resting, during activity and in response to digital pressure. Painful symptoms, quantified according to Scott-Huskisson's scale, disappeared in the majority of patients two months after the end of treatment. No collateral effects were recorded. Thymopentin may therefore be put forward as a useful alternative to cortisone compounds in the treatment of not severe degenerative joint pathologies.